Feng Zhang named a runner-up for TIME’s 2016 Person of the Year
MIT and Broad Institute scientist shares recognition with four other scientists for developing CRISPR gene-editing systems.
Targeting genes by the thousands
PhD student Tim Wang uses CRISPR to take a big-picture approach to cancer research.
Feng Zhang named 2016 Tang Prize laureate
Broad Institute/MIT scientist among three honored for CRISPR contributions.
New CRISPR system for targeting RNA
Scientists program C2c2, discovered in bacteria as a viral defense mechanism, to manipulate cellular RNA.
Feng Zhang receives 2016 Canada Gairdner International Award
Broad/MIT scientist among five honored as pioneers of CRISPR-Cas9 system.
Toward a better understanding of the brain
Genome-editing pioneer Feng Zhang hopes his work will shed light on neurological disorders.
Faster drug discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
MIT, Broad scientists overcome key CRISPR-Cas9 genome editing hurdle
Team re-engineers system to dramatically cut down on editing errors; improvements advance future human applications.
New system for human genome editing has potential to increase power and precision of DNA engineering
CRISPR-Cpf1 offers simpler approach to editing DNA; technology could disrupt scientific and commercial landscape.
Researchers engineer new mouse model to study disease
Time-saving tool takes advantage of CRISPR gene-editing technology.
An easier way to manipulate malaria genes
New approach to knocking out parasite’s genes could make it easier to identify drug targets.
3 Questions: Kenneth Oye on the regulation of genetic engineering
Political scientist discusses regulatory gaps in assessing the impact of “gene drives.”
